Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Kuala Lumpur - Delayed Quote MYR

Pharmaniaga Berhad (7081.KL)

0.2500
-0.0100
(-3.85%)
As of 4:01:44 PM GMT+8. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MYR.
NameTitlePayExercisedYear Born
Mr. Zulkifli Bin Jafar Deputy CEO, Managing Director & Director 1.31M -- 1972
Ms. Norai'ni Binti Mohamed Ali Chief Financial Officer -- -- 1967
Mr. Ahmad Shahredzuan Bin Mohd Shariff Chief Operating Officer 127.5k -- 1983
Dr. Badarulhisam Abdul Rahman Chief Scientific Officer -- -- 1968
Mr. Zulhazri bin Razali Executive Vice President of Commercial - Government Business -- -- 1967
Ms. Wan Intan Idura Wan Ismail Chief Governance Officer & Company Secretary -- -- 1981
Mr. Hayat Al-Mazli Yahaya Acting Head of Human Capital Management & Administration -- -- --
Mr. Mahendran Punusamy Head of Private Marketing & Sales -- -- 1976
Mr. Ahmad Bin Abu Bakar Head of Indonesia Operations -- -- 1969
Mr. Mohd Izwan Ishak Executive Vice President of Manufacturing -- -- 1980

Pharmaniaga Berhad

No. 7, Lorong Keluli 1B
Kawasan Perindustrian Bukit Raja Selatan Seksyen 7
Shah Alam, 40000
Malaysia
60 3 3342 9999 https://www.pharmaniaga.com
Sector: 
Healthcare

Description

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.

Corporate Governance

Pharmaniaga Berhad’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 26, 2025 at 10:59 AM UTC - May 30, 2025 at 12:00 PM UTC

Pharmaniaga Berhad Earnings Date

Recent Events

December 8, 2022 at 12:00 AM UTC

Ex-Dividend Date